Novavax, Inc. (NASDAQ:NVAX)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.

Recs

0
Player Avatar cecamadocv1 (100.00) Submitted: 8/30/2011 1:36:38 PM : Outperform Start Price: $1.94 NVAX Score: -43.51

Im just following the crowd on this one. Insider buying, sitting on money. Things are looking good... So why not?

Featured Broker Partners


Advertisement